Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Subgenual cingulate cortical activity predicts the efficacy of electroconvulsive therapy.

Argyelan M, Lencz T, Kaliora S, Sarpal DK, Weissman N, Kingsley PB, Malhotra AK, Petrides G.

Transl Psychiatry. 2016 Apr 26;6:e789. doi: 10.1038/tp.2016.54.

2.

Ketamine modulates subgenual cingulate connectivity with the memory-related neural circuit-a mechanism of relevance to resistant depression?

Wong JJ, O'Daly O, Mehta MA, Young AH, Stone JM.

PeerJ. 2016 Feb 16;4:e1710. doi: 10.7717/peerj.1710.

3.

Brain Structural Effects of Antidepressant Treatment in Major Depression.

Dusi N, Barlati S, Vita A, Brambilla P.

Curr Neuropharmacol. 2015;13(4):458-65. Review.

4.

Interaction of methamphetamine abuse, tobacco abuse, and gender in the brain.

O'Neill J.

Am J Drug Alcohol Abuse. 2015;41(4):269-71. doi: 10.3109/00952990.2015.1043439. No abstract available.

5.

Neuroimaging-based biomarkers for treatment selection in major depressive disorder.

Dunlop BW, Mayberg HS.

Dialogues Clin Neurosci. 2014 Dec;16(4):479-90. Review.

6.

A systematic review of relations between resting-state functional-MRI and treatment response in major depressive disorder.

Dichter GS, Gibbs D, Smoski MJ.

J Affect Disord. 2015 Feb 1;172:8-17. doi: 10.1016/j.jad.2014.09.028. Review.

7.

Circadian dysregulation of clock genes: clues to rapid treatments in major depressive disorder.

Bunney BG, Li JZ, Walsh DM, Stein R, Vawter MP, Cartagena P, Barchas JD, Schatzberg AF, Myers RM, Watson SJ, Akil H, Bunney WE.

Mol Psychiatry. 2015 Feb;20(1):48-55. doi: 10.1038/mp.2014.138. Review.

8.

Psychotherapy and Neuroimaging.

Fournier JC, Price RB.

Focus (Am Psychiatr Publ). 2014 Jul 1;12(3):290-298.

9.

Increased coupling of intrinsic networks in remitted depressed youth predicts rumination and cognitive control.

Jacobs RH, Jenkins LM, Gabriel LB, Barba A, Ryan KA, Weisenbach SL, Verges A, Baker AM, Peters AT, Crane NA, Gotlib IH, Zubieta JK, Phan KL, Langenecker SA, Welsh RC.

PLoS One. 2014 Aug 27;9(8):e104366. doi: 10.1371/journal.pone.0104366.

10.

Neuroimaging for psychotherapy research: current trends.

Weingarten CP, Strauman TJ.

Psychother Res. 2015;25(2):185-213. doi: 10.1080/10503307.2014.883088. Review.

11.

Pretreatment brain states identify likely nonresponse to standard treatments for depression.

McGrath CL, Kelley ME, Dunlop BW, Holtzheimer PE 3rd, Craighead WE, Mayberg HS.

Biol Psychiatry. 2014 Oct 1;76(7):527-35. doi: 10.1016/j.biopsych.2013.12.005.

12.

fMRI response to negative words and SSRI treatment outcome in major depressive disorder: a preliminary study.

Miller JM, Schneck N, Siegle GJ, Chen Y, Ogden RT, Kikuchi T, Oquendo MA, Mann JJ, Parsey RV.

Psychiatry Res. 2013 Dec 30;214(3):296-305. Erratum in: Psychiatry Res. 2014 Jun 30;222(3):173-5.

13.

Neural correlates of rapid antidepressant response to ketamine in bipolar disorder.

Nugent AC, Diazgranados N, Carlson PJ, Ibrahim L, Luckenbaugh DA, Brutsche N, Herscovitch P, Drevets WC, Zarate CA Jr.

Bipolar Disord. 2014 Mar;16(2):119-28. doi: 10.1111/bdi.12118.

14.

Psychotherapy and brain plasticity.

Collerton D.

Front Psychol. 2013 Sep 6;4:548. doi: 10.3389/fpsyg.2013.00548. Review.

15.

Toward a neuroimaging treatment selection biomarker for major depressive disorder.

McGrath CL, Kelley ME, Holtzheimer PE, Dunlop BW, Craighead WE, Franco AR, Craddock RC, Mayberg HS.

JAMA Psychiatry. 2013 Aug;70(8):821-9. doi: 10.1001/jamapsychiatry.2013.143.

16.

Predictors of remission in depression to individual and combined treatments (PReDICT): study protocol for a randomized controlled trial.

Dunlop BW, Binder EB, Cubells JF, Goodman MM, Kelley ME, Kinkead B, Kutner M, Nemeroff CB, Newport DJ, Owens MJ, Pace TW, Ritchie JC, Rivera VA, Westen D, Craighead WE, Mayberg HS.

Trials. 2012 Jul 9;13:106. doi: 10.1186/1745-6215-13-106.

17.

Adapting Mindfulness-Based Cognitive Therapy for Treatment-Resistant Depression: A Clinical Case Study.

Eisendrath S, Chartier M, McLane M.

Cogn Behav Pract. 2011 Aug;18(3):362-370.

18.

Pharmacotherapy impacts functional connectivity among affective circuits during response inhibition in pediatric mania.

Pavuluri MN, Ellis JA, Wegbreit E, Passarotti AM, Stevens MC.

Behav Brain Res. 2012 Jan 15;226(2):493-503. doi: 10.1016/j.bbr.2011.10.003.

19.

Cognitive mechanisms of treatment in depression.

Roiser JP, Elliott R, Sahakian BJ.

Neuropsychopharmacology. 2012 Jan;37(1):117-36. doi: 10.1038/npp.2011.183. Review.

20.

Double-blind randomized trial of risperidone versus divalproex in pediatric bipolar disorder: fMRI outcomes.

Pavuluri MN, Passarotti AM, Lu LH, Carbray JA, Sweeney JA.

Psychiatry Res. 2011 Jul 30;193(1):28-37. doi: 10.1016/j.pscychresns.2011.01.005.

Items per page

Supplemental Content

Support Center